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Abstract
COVID-19 is the illness caused by infection with the novel coronavirus SARS-CoV-2. Although myalgia is common in adults, it
has not been noted as a common symptom in children. There have been a few reported cases of COVID-19-associated rhabdo-
myolysis in adults. This case report describes a 16-year-old boy who presented with fever, myalgias, mild shortness of breath
with exertion, and dark-colored urine. COVID-19 PCR was positive. His initial creatinine kinase (CK) level was 427,656 U/L.
Serum creatinine was normal for age. He was treated with isotonic intravenous fluids containing sodium bicarbonate to maintain
urine output of 100–200 mL/h and urine pH > 7.0. His serum creatinine remained normal throughout the hospital stay and he was
discharged on hospital day 12 with a CK of 6526 U/L. To our knowledge, no pediatric cases of COVID-19-associated rhabdo-
myolysis have been previously reported. Adult cases of rhabdomyolysis have been reported and a few reports have noted patients
with elevated CK levels without rhabdomyolysis. Given this pediatric case of COVID-19-associated rhabdomyolysis, pediatric
clinicians should be aware of this complication and manage fluids appropriately in order to prevent acute kidney injury.
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Introduction
COVID-19 is the illness caused by infection with the novel co-
ronavirus SARS-CoV-2. SARS-CoV-2 first emerged in China in
December 2019 and shortly thereafter spread worldwide. In
adults, the most common presenting symptoms are fever (76–
91%), cough (63–65%), fatigue (38.5–50%), dyspnea (14–44%),
anorexia (12–24%), diarrhea (15–28%), and myalgia (11–22%)
[1–3]. In children, fever (36–41.5%), cough (19–48.5%), and
diarrhea (9–12%) are most common [4–6]. Although myalgias
are common in adults, no studies in children noted the presence
of myalgias [4, 5]. There have been a few reported cases of
COVID-19-associated rhabdomyolysis in adults, but no such
cases have been reported in children [7–10].
Rhabdomyolysis is defined as the breakdown of skeletal
muscle leading to leaking of muscle contents into the extra-
cellular fluid [11]. Although there is no official consensus, it is
usually defined by a serum creatine kinase (CK) of > 1000 U/
L, which is five times the upper limit of normal [11]. Patients
with rhabdomyolysis can be asymptomatic or present with
myalgia, weakness, myoglobinuria with dark urine, signifi-
cant electrolyte imbalance, and acute kidney injury [11].
Rhabdomyolysis in children is commonly caused by viral
myositis, trauma, connective tissue disorders, and drug over-
dose [11]. The most common viral causes of rhabdomyolysis
are influenza A and B viruses followed by HIV and enterovi-
ruses [12]. Rarely, other viruses have been reported to cause
rhabdomyolysis, including coronaviruses such as SARS-
CoV-1 [12, 13]. Here we present a case of pediatric
COVID-19-associated rhabdomyolysis.
Case report
A 16-year-old boy with autism spectrum disorder, attention
deficit hyperactivity disorder, morbid obesity, obstructive
sleep apnea, and eczema presented with fever, myalgias,
shortness of breath with exertion, and dark-colored urine.
Five days prior to admission, he began to feel fatigue. Four
days prior to admission, he noted myalgias of his arms, legs,
abdomen, and back, as well as mild shortness of breath on
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exertion. One day prior to admission, he was evaluated by an
urgent care center where he was febrile to 38.9 °C. He denied
any congestion, rhinorrhea, anosmia, inability to taste, dys-
uria, nausea, vomiting, or diarrhea. Of note, he was found to
have cola-colored urine. When asked about the duration of
dark urine, he stated it had been occurring for 2 days, but his
mother was not certain that his estimation was accurate given
his autism spectrum disorder. He took acetaminophen inter-
mittently in the days prior and denied taking any non-steroidal
anti-inflammatory agents. The family history was significant
for hypertension and type 2 diabetes mellitus.
In the emergency department, vital signs were as follows:
maximum temperature of 37.8 °C, heart rate of 122 BPM, respi-
ratory rate of 18–20 breaths/min, and oxygen saturation of 99–
100% on room air. His blood pressure was initially elevated at
133/87mmHg but lowered to normal rangewithout intervention.
He was well appearing on exam, with the only focal findings
being pharyngeal erythema and diffuse abdominal pain. Initial
laboratory work-up revealed a slight elevation in white blood cell
count at 10.74 K/uL and slightly low platelets at 138 K/uL.
Serum creatinine was normal for age at 0.89 mg/dL and electro-
lytes were within normal range. AST and ALT were elevated at
839 U/L and 157 U/L, respectively, and GGT was normal at
37 U/L. Urinalysis showed a pH of 6.0, large blood with 11–
25 RBC/HPF and 6–10 WBC/HPF. Random urine protein-to-
creatinine ratio was elevated at 0.81 mg/mg. Kidney ultrasound
with Doppler and abdominal ultrasound were normal.
Respiratory pathogen PCR panel was negative, but COVID-19
PCR was positive. Hepatitis and cytomegalovirus serologies
were negative. Epstein-Barr serologies were indicative of re-
solved past infection. Antistreptolysin O screen was not elevated
and throat culture was negative. C3 and C4 were normal.
Antinuclear antibody, double-stranded DNA, and anti-
glomerular basement membrane IgG results were all negative.
The patient’s CK level was 427,656 U/L.
On admission, vital signs were as follows: weight 162 kg,
body mass index 54.3 kg/m2 (> 99th percentile), blood pres-
sure 122/72mmHg, temperature 37.7 °C, heart rate 110 BPM,
respiratory rate 20 breaths/min, and oxygen saturation of 98–
100% on room air. Physical exam was notable for obesity,
acanthosis nigricans, and tenderness to palpation of distal an-
terior lower legs. Repeat CK was 296,396 U/L. Urine myo-
globin was sent but did not result. His sodium decreased to
130 mmol/L, albumin decreased to 3.2 g/dL, and creatinine
remained normal for age at 0.68 mg/dL. Ferritin was normal,
but procalcitonin (0.22 ng/mL), lactate dehydrogenase
(2184 U/L), C-reactive protein (24.9 mg/L), and troponin
(58 ng/L) were elevated. Echocardiogram was normal.
Toxicology screen was negative. Incidentally, hemoglobin
A1c was found to be elevated in the diabetic range at 8.2%.
He was given a 1000 mL normal saline bolus and started on
isotonic intravenous fluids containing sodium bicarbonate and
potassium chloride at 200 mL/h.
On hospital day 2, CK was down to 108,059 U/L. Sodium
and albumin normalized. Urine pHwas > 7.0. On hospital day
4, he continued to have significant myalgias requiring acet-
aminophen and morphine. His fluids were reduced to 100 mL/
h as his CK had decreased to 53,977 U/L, and his serum
creatinine remained normal. However, on hospital day 6, his
CK doubled from the previous day to 159,675 U/L, and his
fluids were increased back to 200 mL/h. His blood pressures
became persistently elevated and amlodipine 5 mg daily was
initiated. Starting on hospital day 7, he no longer complained
of myalgias and did not require further analgesic medications.
On hospital day 9, his CK was 36,294 U/L and his urine was
negative for blood, so the fluid rate was decreased. Urine
myoglobin was resent and was elevated at 45 mcg/L. On hos-
pital day 11, his CK was 11,732 U/L and urine remained
negative for blood. His fluids were stopped along with his
amlodipine as his blood pressures normalized. He was
discharged on hospital day 12 with a CK of 6526 U/L. The
CK trend is illustrated in Fig. 1.
Discussion
Herein, we present a case of severe rhabdomyolysis without
acute kidney injury that was associated with COVID-19 in-
fection in a pediatric patient. To our knowledge, no cases of
COVID-19-associated rhabdomyolysis have been previously
reported in children or adolescents.
A few adult cases have been reported recently, none of
which had CK levels nearly as high as our patient’s. In a
series of 1099 patients with COVID-19 in China, 2 pa-
tients were diagnosed with rhabdomyolysis. The ages of
these patients were not specified, but of all the study pa-
tients, < 1% of patients were less than 15-years-old [10].
Another group in China analyzed the autopsies of 26 adult
patients with COVID-19 and found pigmented casts asso-



















Fig. 1 Creatine kinase trend over time
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COVID-19-associated rhabdomyolysis was reported in a
60-year-old male in Wuhan, China, with a maximum CK
of 17,434 U/L without any subsequent acute kidney injury
[14]. The only case of COVID-19-associated rhabdomy-
olysis reported in the USA was of an 88-year-old male
with a maximum CK of 13,581 U/L with subsequent de-
velopment of mild acute kidney injury that resolved with
intravenous fluid administration [8].
Several studies from China reported patients with elevated
CK levels without development of rhabdomyolysis. In a study
of 95 adults, 12 had CK levels 200–400 U/L, 9 had levels
400–600 U/L, and 7 had levels > 600 U/L [15]. In a study of
91 adults, 14 had CK levels > 190 U/L and 15 had myalgias,
but there is no indication if those with elevated CK were those
with myalgias [3]. In a study of 161 adults, 17 had CK levels
> 190 U/L and 18 had myalgias, but there is no indication if
those elevated CK were those with myalgias [1]. The only
pediatric study that assessed CK levels involved 32 children
and found that no patients had rhabdomyolysis and only one
patient had CK > 170 U/L [4].
In general, the pathogenesis of different types of viral rhab-
domyolysis has been debated and includes direct invasion of
the muscle by virus, cytokine storm resulting in muscle dam-
age, and muscle injury by circulating viral toxins. Chen et al.
postulated that SARS-CoV-1-associated rhabdomyolysis was
secondary to cytokine storm rather than direct viral invasion
due to the presence of high inflammatory markers and the lack
of viral particles on muscle biopsies [13]. There are no reports
of muscle biopsies in patients with COVID-19-associated rhab-
domyolysis, but similar to SARS, COVID-19 is also associated
with high inflammatory markers. This may indicate that rhab-
domyolysis in COVID-19 could be cytokine-mediated.
In conclusion, this case illustrates a pediatric patient
who presented with myalgia and severe rhabdomyolysis
in the setting of COVID-19 infection. Rhabdomyolysis
and elevated CK may be under-recognized complica-
tions of COVID-19 in pediatrics. Given this pediatric
case of COVID-19-associated rhabdomyolysis and the
multiple reports in adults, pediatric clinicians should
be aware of this complication. We recommend checking
CK levels in pediatric patients presenting with myalgia,
especially those with urinary changes or acute kidney
injury. When treating rhabdomyolysis, aggressive fluid
administration is important to prevent acute kidney in-
jury. However, it is especially important to monitor for
signs of heart failure and pulmonary edema as these
complications can occur in COVID-19 patients even
without aggressive fluid administration.
Authors’ contributions AG performed the literature search. AG and CS
wrote the first draft of the manuscript. All authors contributed to the
critical appraisal of the manuscript and have approved the final version
of the manuscript that was submitted.
Data availability Data will be made available upon request.
Compliance with ethical standards
Conflicts of interest The authors declare that they have no conflict of
interest.
References
1. Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG (2020)
Clinical characteristics of 161 cases of corona virus disease 2019
(COVID-19) in Changsha. Eur Rev Med Pharmacol Sci 24:3404–
3410
2. Chen T,WuD, Chen H, YanW, YangD, Chen G,MaK, Xu D, Yu
H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J,
HanM, Li S, Luo X, Zhao J, Ning Q (2020) Clinical characteristics
of 113 deceased patients with coronavirus disease 2019: retrospec-
tive study. BMJ 368:m1091
3. Zhao XY, XuXX, Yin HS, Hu QM, Xiong T, Tang YY, Yang AY,
Yu BP, Huang ZP (2020) Clinical characteristics of patients with
2019 coronavirus disease in a non-Wuhan area of Hubei Province,
China: a retrospective study. BMC Infect Dis 20:311
4. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D (2020) Clinical and
epidemiological features of 36 children with coronavirus disease
2019 (COVID-19) in Zhejiang, China: an observational cohort
study. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)
30198-5
5. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y,
Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z,
XiangY, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S,
Wong GWK (2020) SARS-CoV-2 infection in children. N Engl J
Med 382:1663–1665
6. Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, Li XL,
Chen CX, Lu XX, Liu ZS, Lu W, Chen CB, Jiao R, Zhang AM,
Wang JT, Ding XW, Zeng YG, Cheng LP, Huang QF, Wu J, Luo
XC, Wang ZJ, Zhong YY, Bai Y, Wu XY, Jin RM (2020) Clinical
characteristics of children with coronavirus disease 2019 in Hubei,
China. Curr Med Sci 40:275–280
7. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC,
Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis
of 26 postmortem findings of patients with COVID-19 in China.
Kidney Int. https://doi.org/10.1016/j.kint.2020.04.003
8. Suwanwongse K, Shabarek N (2020) Rhabdomyolysis as a presen-
tation of 2019 novel coronavirus disease. Cureus 12:e7561
9. Ronco C, Reis T (2020) Kidney involvement in COVID-19 and
rationale for extracorporeal therapies. Nat Rev Nephrol. https://doi.
org/10.1038/s41581-020-0284-7
10. GuanWJ, Ni ZY, Hu Y, LiangWH, Ou CQ, He JX, Liu L, Shan H,
Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang
CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng
YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li
G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020)
Clinical characteristics of coronavirus disease 2019 in China. N
Engl J Med 382:1708–1720
11. Al-Ismaili Z, Piccioni M, Zappitelli M (2011) Rhabdomyolysis:
pathogenesis of renal injury and management. Pediatr Nephrol
26:1781–1788
12. Crum-Cianflone NF (2008) Bacterial, fungal, parasitic, and viral
myositis. Clin Microbiol Rev 21:473–494
13. Chen LL, Hsu CW, Tian YC, Fang JT (2005) Rhabdomyolysis
associated with acute renal failure in patients with severe acute
respiratory syndrome. Int J Clin Pract 59:1162–1166
Pediatr Nephrol
14. Min J, Tong Q (2020) Rhabdomyolysis as potential late complica-
tion associated with COVID-19. Emerg Infect Dis 26(7). https://
doi.org/10.3201/eid2607.200445
15. Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S (2020)
Analysis of clinical characteristics and laboratory findings of 95
cases of 2019 novel coronavirus pneumonia in Wuhan, China: a
retrospective analysis. Respir Res 21:74
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Pediatr Nephrol
